People with high blood pressure typically take tablets daily to control the condition – and ACE inhibitors are the most common.
But exciting research is being made into a long-acting injection that could revolutionise how hypertension is treated.
Scientists at Queen Mary University of London and Barts Health NHS Trust are leading a global trial involving 630 patients, 100 of them in the UK.
